Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
QIAGEN Expands QIAstat-Dx Testing Menu With Respiratory 4-Plex Panel That Differentiates Between Flu, RSV And SARS-CoV-2
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch and CE-marking of the QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test for the QIAstat-Dx system to quickly identify whether
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Redburn Partners Initiates Coverage On Qiagen with Buy Rating
Redburn Partners analyst Simon Baker initiates coverage on Qiagen (NYSE:QGEN) with a Buy rating.
FDA Warns Of Potential For False Positive Results With Certain Lots Of Ellume COVID-19 Home Tests Due To Manufacturing Issue
https://www.fda.gov/medical-devices/safety-communications/potential-false-positive-results-certain-lots-ellume-covid-19-home-tests-due-manufacturing-issue-fda
Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx
Qiagen NV (NYSE:QGEN) won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and…
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date
QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that the number of biological samples processed with consumables kits has passed the three billion mark – a record that underlines its
The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 10)